The Invisible Cost Transfer

Every year, the ritual repeats: the broker arrives with the renewal numbers, the CFO winces, the HR director absorbs the impact, and the company adjusts—higher deductibles here, a larger employee premium contribution there. The assumption embedded in that ritual is that health-care costs rise because health care gets more expensive. That assumption isn’t wrong, exactly. But it’s dangerously incomplete.

What is actually driving the acceleration in employer-sponsored plan costs right now is a structural transfer—a systematic migration of financial risk from government programs and hospital balance sheets onto the employer health plans that cover roughly 164 million working Americans. The mechanisms are distinct, but they operate in the same direction and increasingly at the same time. Kansas City executives who understand those mechanisms are in a position to respond strategically. Those who don’t will keep absorbing the consequences without understanding the cause.

Explaining Medicaid Math

When Congress debates Medicaid, the conversation is framed in terms of beneficiaries: who loses coverage, how many, what populations. That framing is accurate as far as it goes—and the numbers are substantial. The One Big Beautiful Bill Act, signed into law on July 4, 2025, authorizes roughly $1 trillion in federal Medicaid spending reductions over 10 years. The Congressional Budget Office estimates that 11.8 million people will lose Medicaid coverage as a result, primarily through new work-requirement reporting mandates that will cause many technically eligible enrollees to lose coverage without ever being formally declared ineligible.

What the coverage headlines don’t explain is what happens next—specifically, what happens to the hospitals and health systems that continue treating those patients after their Medicaid cards stop working.

The mechanism is well documented in health economics research but rarely explained to business audiences. Hospitals, by law and by mission, provide care to patients regardless of their ability to pay. When those patients are uninsured or underinsured, the hospital absorbs the cost as uncompensated care. To recover financially, it raises rates on the patients it can bill—meaning those covered by commercial insurance. That commercial insurance, overwhelmingly, means employer-sponsored plans.

The cost transfer doesn’t appear as a line item on any renewal document. It’s laundered through the commercial market into the aggregate premium calculation and surfaces, invisibly, as part of the medical trend rate your broker uses to justify next year’s increase. There is no notification. There is no negotiation. The invoice simply arrives, higher than last year, for reasons left the employer to infer.

Missouri’s specific profile adds regional dimension to this dynamic. The state expanded Medicaid under the ACA only in 2021—relatively recently, compared to states that have had expansion populations for a decade or more. That means Missouri’s newly insured expansion population is now among those most exposed to disenrollment disruptions from OBBBA’s work requirement and eligibility verification provisions. The Kansas City metro market straddles a state line, which creates an additional layer of complexity: Missouri employers with workforces that include Medicaid-enrolled dependents face a different actuarial risk profile than their counterparts in states with longer, more stable expansion histories.

“As Medicaid eligibility and payment rules tighten over the next several years, hospitals will see an increase in uninsured patients and non-reimbursable costs. Those costs will have to be recouped somewhere, and it is reasonable to assume commercial insurance rates will rise.”

   —  Mike Bukaty, CEO, Bukaty Companies, Leawood

Bukaty’s read is instructive precisely because it’s measured rather than alarmist: the cost shift isn’t a current crisis for most area employers; it’s a coming one—which means there’s still a window for employers to model their exposure before it shows up uninvited on a renewal invoice. How any of this translates to a specific employer’s plan depends heavily on workforce composition, geographic footprint, and existing plan structure—which is precisely the question every employer should be putting to their benefits adviser before the next renewal cycle, not after it.

Inside Pricing Power

The second structural driver operates closer to home and has been accumulating for years. Hospital and health system consolidation in concentrated regional markets has created provider entities with pricing leverage that most employers—and many insurers—cannot effectively counter.

The data on this relationship is not ambiguous. A KFF analysis found that as of 2023, one or two health systems provided all inpatient commercial hospital care in approximately half of U.S. metropolitan areas. Federal health data has documented that horizontal hospital mergers in concentrated markets can raise hospital prices anywhere from 6-65 percent. Physician-practice acquisitions by hospital systems have been linked to average price increases of 14 percent for those services. A 2025 National Bureau of Economic Research study examining anesthesia provider rollups found that once a single entity achieved dominance in a market, prices paid by employer-sponsored plans rose 18 percent within six months of the consolidation.

The mechanism is straightforward: when a single integrated system owns the dominant hospital, the dominant physician group, the dominant imaging facilities, and the dominant ambulatory surgery centers in a given corridor, commercial insurers face a binary choice at the negotiating table—accept the system’s price demands or exclude the system from their network entirely. In concentrated markets, exclusion is rarely viable. So rates rise, and those rates flow directly into the premiums that employers pay.

For Kansas City employers, this is not a theoretical concern. The metro market is served by major integrated health systems with significant regional market share across both Missouri and Kansas. The practical consequence is that even a well-managed, fully-insured employer plan has limited protection against the underlying price structure—because that price structure was set in negotiations between the insurer and the health system, in a room the employer was never invited to enter.

This is where plan structure matters in ways most mid-market employers haven’t fully considered. Employers on self-funded plans have a fundamentally different relationship to the pricing data than those on fully insured arrangements. They have the contractual standing to demand transparency into what their plan is actually paying for specific services at specific facilities.

Bukaty’s point is a useful corrective to the way this conversation is often framed. The choice isn’t a binary leap from fully-insured to fully self-funded—it’s a spectrum, and there are intermediate structures, including level-funding and captive arrangements, that let an employer dial in exactly how much risk and visibility it wants to take on. It involves a risk-tolerance conversation that most employers have never been walked through.

The price-transparency tools that could change this equation are improving, but unevenly. The Trump administration’s January 2026 health-care pricing initiative includes new requirements for any provider accepting Medicare or Medicaid to post pricing publicly, and bipartisan legislation in Congress is pushing the same direction. Independent analysis has found compliance with existing transparency rules to be inconsistent—a 2024 Purchaser Business Group on Health report identified fee categories hidden from employer plan sponsors, raising questions about how much pricing information has been concealed since transparency requirements first took effect. The tools are being forged. Most KC employers haven’t picked them up yet.

The Renewal-Invoice Impact

The convergence of these two dynamics—the Medicaid cost-shift accelerating under OBBBA, and hospital pricing power in concentrated markets—is landing on employer plans at precisely the moment when the underlying cost trend was already at its steepest in 15 years. Mercer’s 2025 national survey of employer-sponsored plans found that total health benefit cost per employee reached $17,496 in 2025, a 6 percent increase well above the rate of inflation and wage growth. The firm projects a further 6.7 percent increase in 2026, pushing average per-employee cost above $18,500—the steepest sustained increase trajectory since 2010.

Employers are responding in the ways available to them within a fully-insured framework: 59 percent say they plan to raise deductibles and cost-sharing in 2026, up from 48 percent the year before. That response shifts costs to employees at the point of care—which, in a tight labor market, is a talent and compensation decision as much as a benefits-administration one. Health-benefit costs are consuming compensation budget that would otherwise go to wages, and employees increasingly recognize the trade-off when comparing offers.

Yet despite all of this structural pressure, the conversations area employers are having with their brokers and consultants may be healthier than the national narrative suggests. That year-round posture is, in itself, a meaningful data point for the feature’s argument. The employers most exposed to the structural pressures described here are the ones who treat the broker relationship as a once-a-year transaction. The ones positioned to respond—through plan redesign, network strategy, or a genuine evaluation of self-funded options—are the ones who’ve made benefits strategy a continuous conversation rather than an annual fire drill.

There is no single adjustment that neutralizes the structural pressures described here. The Medicaid cost shift will continue to grow as OBBBA provisions phase in through 2026 and beyond. Hospital market concentration in major metros is not reversing quickly, regardless of what federal antitrust policy does at the margins. But employers who understand the architecture—who can see where the costs are actually originating and why—are positioned to make decisions that those still operating on autopilot are not. That difference, compounded over multiple renewal cycles, is material.

PUBLISHED JUNE 2026